This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—We welcome Dr Schechter's letter as it gives us the opportunity to clarify some points that may have led to misinterpretation in our paper. The patient in our report was initially treated with two topically applied bacteriostatic agents, and was later treated with systemically and topically administered penicillin. It is neither our usual practice nor our recommendation to use bacteriostatic agents for a hyperacute conjunctivitis or to use topically applied penicillin for a possible gonococcal conjunctivitis; we were reporting the treatment received.When a patient is seen with a hyperacute conjunctivitis that shows Gram-negative intracellular diplococci on smear, the diagnosis must be gonococcal conjunctivitis until proven otherwise. It is our opinion that gonococcal conjunctivitis is a systemic disease and should be so treated. We did not discuss the antibiotic treatment of gonococcal conjunctivitis since it was not germane to our paper.With regard to the possibility
Wand M, Olive GM, Mangiaracine AB. Treatment of Mima polymorphia Conjunctivitis-Reply. Arch Ophthalmol. 1976;94(2):339. doi:10.1001/archopht.1976.03910030176021
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: